Constipation Clinical Research Trials

Birmingham : Achieve Clinical Research, LLC an Accel Research Site

A research study to evaluate the long term safety and tolerability of CB-5945 for the treatment of Opioid-induced constipation in adults taking opioid therapy for chronic pain.

Alabaster : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Alabaster : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Birmingham : Alabama Clinical Therapeutics

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Birmingham : Alliance Clinical Trials

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Birmingham : Cahaba Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Birmingham : Radiant Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Birmingham :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Birmingham : Cahaba Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Dothan : Digestive Health Specialists of the Southeast

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Dothan : Digestive Health Specialists of the Southeast

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Foley : G and L Research, LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Foley : G & L Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Gulf Shores : Fundamental Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Gulf Shores :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Homewood : Central Alabama Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Homewood : Central Alabama Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Huntsville : Clinical Research Associates

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Huntsville : Medical Affiliated Research Center, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Huntsville : Longwood Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Huntsville : Clinical Research Associates

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Huntsville :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Mobile : WILMAX Clinical Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Mobile : Alabama Orthopaedic Clinic

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Mobile : Mobile Medical Diagnostic

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Mobile : WILMAX Clinical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Mobile : USA Pavilion at Infirmary West

Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications

North Mobile :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Phoenix : Elite Clinical Studies, LLC

Abdominal Pain related to Constipation? Suffer frequent Bloating or Cramping?

Phoenix : Arizona Research Center

Opioid Induced Constipation

Phoenix : Arizona Research Center

Opioid Induced Constipation study

Glendale : Arrowhead Family Health Center PC dba Arrowhead Health Centers

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Goodyear : Sage Health LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Goodyear : Dedicated Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Mesa : Agave Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Mesa :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Peoria : Pivotal Research Centers

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Phoenix : The Pain Center of Arizona

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Phoenix : Dedicated Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Phoenix : Phoenix Clinical

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Phoenix : The Pain Center of Arizona

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Phoenix : Elite Clinical Studies, LLC.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Phoenix :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Scottsdale : Radiant Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Scottsdale : Mayo Clinic Arizona

Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

Sun Lakes : Clinical Research Consortium Arizona

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Sun Lakes : Clinical Research Consortium Arizona

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Tempe : Clinical Research Advantage, Inc./ Colorado Springs Health Partners, PC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tempe : Clinical Research Advantage, Inc./ Colorado Springs Health Partners, PC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Tucson : Genova Clinical Research, Inc.

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Tucson : Adobe Gastroenterology Research, LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Tucson : Quality of Life Medical & Research Center, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tucson : Genova Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tucson : Genova Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Tucson : Genova Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Tucson : Adobe Clinical Research , LLC

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Tucson : Visions Clinical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Tucson :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Tucson : Adobe Clinical Research, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Tucson : Genova Clinical Research, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Hot Springs : Central Arkansas Pain Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Hot Springs : Central Arkansas Pain Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Hot Springs :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Little Rock : Preferred Research Partners

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Little Rock : Preferred Research Partners, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Little Rock : Aureus Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Little Rock : Preferred Research Partners

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Little Rock :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Little Rock : Lynn Institute of the Ozarks

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

North Little Rock : Arkansas Gastroenterology

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

North Little Rock :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Sherwood : Moore Clinical Trials LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Sherwood : Arkansas Gastroenterology

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Walnut Creek : Diablo Clinical Research

A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation

Anaheim : ACRI - Phase 1, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Anaheim : Global Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Anaheim : Advanced Research Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Anaheim : Global Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Anaheim : ACRI - Phase 1, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Anaheim : Anaheim Clinical Trials

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Anaheim : Anaheim Clinical Trials, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Artesia : Advanced Rx Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Artesia :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Beverly Hills : Impact Clinical Trials

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Cerritos : Skyline Research LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Cerritos : Skyline Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Cerritos :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chino : Catalina Research Institute, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Chino : Catalina Research Institute, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Chula Vista : GW Research, Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Chula Vista : GW Research, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Encinitas : Discovery Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Encino : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Foothill Ranch : Family Medical Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Fountain Valley : Allianz Medical and Research Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Fountain Valley : Allianz Medical and Research Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Fresno : Valley Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Fresno : Fresno Family Medical Clinic

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Fresno : Fresno Family Medical Clinic

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Fresno : Valley Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Fresno : Advanced Medical Research Institute

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Fresno :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Garden Grove : Paradigm Clinical, Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Garden Grove : Rx Clinical Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Garden Grove : SC Clinical Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Garden Grove : Digestive and Liver Disease Specialist, A Medical Group, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Garden Grove : SC Clinical Research, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Glendale : Behavioral Research Specialists, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Huntington Park :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

La Mesa : TriWest Research Associates

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

La Mesa : TriWest Research Associates

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

La Mesa :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Laguna Hills : Pacific Coast Pain Management Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Laguna Hills : South Orange County Surgical Medical Group

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Laguna Hills : Pacific Coast Pain Management Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Laguna Hills :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Lakewood : Lakewood Primary Care Medical Group, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Lincoln : Clinical Trials Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Lincoln :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Lomita : Torrance Clinical Research Institute, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Long Beach : Long Beach Center for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Long Beach : Skyline Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Long Beach : Long Beach Center for Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Long Beach :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Los Angeles : David Geffen School of Medicine at University of California, Los Angeles

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Los Angeles : West Gastroenterology Associates

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Los Angeles : L.A. Pain and Wellness Institute

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Los Angeles : MD Clinical Trials

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Los Angeles : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Los Angeles :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Los Gatos : Samaritan Center for Medical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Los Gatos : Samaritan Center for Medical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Mission Viejo : Prime Care Clinical Research, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

National City : Synergy Clinical Research Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Norco :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

North Hollywood : Providence Clinical Research

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

North Hollywood : Providence Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

North Hollywood : Translational Research Group

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Oceanside : Pacific Sleep Medicine, A Medical Corporation

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Oceanside : North County Clinical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Orange : SDS Clinical Trials, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Orange : Elias Research Associates

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Orange : Community Clinical Trials

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Orange : University of California, Irvine Medical Center

Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome

Paramount : Bayview Research Group, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Paramount : Bayview Research Group, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Pasadena : Healthcare Partners Medical Group

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Richmond : Center for Clinical Research, Inc

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Richmond : Center for Clinical Research, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Roseville : Trinity Medical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sacramento : Sacramento Research Medical Group

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Sacramento : Center for Clinical Trials of Sacramento, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Sacramento : Quality Control Research, Inc

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Sacramento : Center for Clinical Trials of Sacramento, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sacramento : Quality Control Research, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sacramento : Benchmark Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

San Bernardino : BreakThrough Clinical Trials, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

San Diego : Precision Research Institute, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

San Diego : Precision Research Institute, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

San Diego : Medical Center for clinical research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

San Diego : California Research Foundation

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

San Diego : Precision Research Institute, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

San Diego :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

San Diego : Medical Center for Clinical Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

San Francisco : Shawn K Hassler

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

San Francisco : Sprim

Multistrain Probiotic for Functional Constipation

Santa Ana : Trinity Clinical Trials

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Santa Clarita : Clearview Medical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Thousand Oaks : Southern California Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Valley Village : Bayview Research Group, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Valley Village : Bayview Research Group, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Vista : Progressive Clinical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Westlake Village : Westlake Medical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Denver : Horizons Clinical Research Center, LLC

Horizons Clinical Research Center, LLC is now enrolling volunteers to participate in a clinical research study for the treatment of chronic constipation.

Aurora : Salix Investigational Site

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Aurora : Salix Investigational Site

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Castle Rock : Clinical Trial Center of Colorado, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Colorado Springs : Expresscare Plus

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Colorado Springs : Expresscare Plus

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Colorado Springs :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Colorado Springs : Lynn Institute of the Rockies

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Denver : Lynn Institute of Denver

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Denver : Radiant Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Denver : Horizons Clinical Research Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Denver : Lynn Institute of Denver

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Denver :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Denver : Horizons Clinical Research Center, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Golden : Red Rocks Center for Rehabilitation

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Golden : Red Rocks Center for Rehabilitation

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Waterbury : Chase Medical Research, LLC

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Efficacy (Compared to Placebo) and the Management of Opioid-induced Constipation (Compared to Oxycodone Controlled-release Tablets (OXY)) in Opioid-experienced Subjects with Uncontrolled Moderate to Severe Chronic Low Back Pain and a History of Opioid-induced Constipation who Require Around-the-clock Opioid Therapy.

Bridgeport : Gastroenterology Associates of Fairfield County

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

New Haven : Advanced Diagnostic Pain Treatment Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Stamford : Stamford Therapeutics Consortium

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Waterbury : Chase Medical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Waterbury : Chase Medical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Fort Myers : Clinical Physiology Associates

Moderate to Severe Chronic Low Back Pain and a History of Opioid-Induced Constipation

Fort Myers : Clinical Physiology Associates

Opioid-Induced Constipation

Miami : IMA Research

A research study is currently underway in your area to test the safety and effectiveness of an investigational medication to help treat moderate-severe low back pain and the constipation that may occur in people taking prescription pain medications.

Ocala : Renstar Medical Research

Do You Suffer from Constipation?

Panama City : Emerald Coast Research Associates

Research study for volunteers at least 18 years of age who are currently experiencing symptoms of chronic constipation

Port Orange : Accord Clinical Research, LLC an Accel Research Site

Chronic Constipation

Tampa : Clinical Research of West Florida

Opioid Induced Constipation Bringing Your Life To A Standstill? Get Moving and Join our OIC Research Study

West Palm Beach : Palm Beach Research Center

Don't know why your constipated?

West Palm Beach : Palm Beach Research Center

Suffering from chronic low back pain?
Along with constipation?

Aventura : Orthopaedic Specialist of Miami Beach

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Aventura : Orthopaedic Specialist of Miami Beach

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Aventura : Interventional Rehab of South Florida

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Boca Raton : Clinical Trials Management of Boca Raton, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Boynton Beach : Zasa Clinical Research

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Boynton Beach : Orthopedic Research Institute

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Boynton Beach : Consultants for Clinical Research of South Florida

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Bradenton : Meridien Research

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Bradenton : Coastal Orthopedics & Sports Medicine

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Bradenton : Coastal Orthopedics & Sports Medicine

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Brandon : PAB Clinical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Brandon :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Brooksville :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chiefland : Southeast Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Clearwater : Clinical Research of West Florida, Inc

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Clearwater : Clinical Research of West Florida, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Clearwater : Elite Trials

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Clermont : South Lake Pain Institute

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Clermont : South Lake Pain Institute

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Coral Gables : Sanitas Research

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Coral Gables : Sanitas Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Crystal River :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Daytona Beach : Century Clinical Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Daytona Beach : Century Clinical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Deland : Avail Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

DeLand :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Edgewater : Riverside Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Eustis : Lake Internal Medicine Associates

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Fort Lauderdale : Shrock Orthopedic Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Fort Lauderdale : Shrock Orthopedic Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Fort Myers : Clinical Physiology Associates

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Fort Myers :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Hialeah : Health Care Family Rehab Corp.

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Hialeah : Future Care Solution, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Hialeah : Health Care Family Rehab & Research Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Hialeah : Palm Springs Research Institute

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Hialeah : Eastern Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Hialeah : Health Care Family Rehabilitation and Research Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Hialeah :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Hialeah : Medical Research Unlimited, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Hollywood : Center for Gastrointestinal Disorders

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Inverness : Nature Coast Clinical Research, LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Inverness : Nature Coast Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Inverness : Nature Coast Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Inverness :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Jacksonville : Southeast Clinical Research, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Jacksonville : Gastroenterology and Hepatology Associates

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Jacksonville : Southeast Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Jacksonville : East Coast Institute for Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Jacksonville : East Coast Institute for Research, LLC / Jacksonville Pain Center, PA

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Jacksonville : Clinical Neuroscience Solutions, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Jacksonville : Jacksonville Center for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Jacksonville : East Coast Institute for Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Jacksonville : Florida Institute of Medical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Jacksonville : Southeast Clinical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Jacksonville : Jacksonville Center for Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Jacksonville : Mayo Clinic Florida

Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

Jacksonville :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Jupiter : Health Awareness, Inc.

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Jupiter : Jupiter Research Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Jupiter : Jupiter Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Jupiter : Drug Study Institute

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Jupiter : Health Awareness ,Inc

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Jupiter :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Jupiter : Jupiter Research, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Jupiter : Health Awareness, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Leesburg :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Maitland : Center for Advanced Gastroenterology

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Maitland :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Maitland : MNH Surgical Center

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Miami : Research Institute of South Florida

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Miami : AMPM Research Clinic

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : Pharma Care Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : Amun Medical Research Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : Finlay Medical Research Corp.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : South Florida Research Phase I-IV, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : Clintex Research Group, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : Pharmax Research Clinic, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : AppleMed Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : Clinical Research of Miami, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : San Marcus Research Clinic, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami : AppleMed Research Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Miami : Clinical Research of Miami, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : Pharmax Research Clinic, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : Prestige Clinical Research Center Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : Kendall South Medical Center, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : IMA Clinical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : Swiss Medical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : Well Pharma Medical Research Corp.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : AMPM Research Clinic

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami : San Marcus Research Clinic

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Miami : Community Research Foundation , Inc.

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Miami : South Medical Research Group , Inc

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Miami : Columbus Clinical Services, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Miami : South Medical Research Group, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Miami Beach : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Miami Lakes : Veritas Research Corp.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miami Springs : Ocean Blue Medical Research Center, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Miramar :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Naples : Gastroenterology Group of Naples

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Naples : Pharma Research International, Inc

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Naples : Pharma Research International, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Naples :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

New Port Richey : Suncoast Clinical Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

New Port Richey : Suncoast Clinical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

New Smyrna Beach : United Medical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

North Miami : Piedmont Clinical Trials, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

North Miami Beach : Harmony Clinical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Ocala :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Oldsmar :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Orlando : Compass Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Orlando : Compass Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Orlando :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Orlando : Compass Research, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Ormond Beach : Ormond Medical Arts Pharmaceutical

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Oviedo : Compass Research East, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Oviedo : Compass Research East, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Pinellas Park : Advent Clinical Research Centers, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Pinellas Park : DMI Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Plant City : Clinical Research of Central Florida

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Plantation : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Plantation : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Plantation :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Port Orange : Accord Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Port Orange : Accord Clinical Research, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Port Orange : Accord Clinical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Port Orange : Accord Clinical Research,LLC

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Port Orange :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Port Orange : Accord Clinical Research, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Port St. Lucie : National Pain Research Institute, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sanford : International Clinical Research - US, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

South Miami : Regenerate Clinical Trials

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

South Miami : South Miami Clinical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

St. Petersburg : Meridian Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

St. Petersburg :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Tamarac : Phoenix Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tamarac : Phoenix Clinical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Tampa : Stedman Clinical Trials

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tampa : Clinical Research Trials of Florida, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tampa : Stedman Clinical Trials

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Tampa : Stedman Clinical Trials

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Tampa : Clinical Research Trials of Florida, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Tampa : Meridian Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Tampa :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Tampa : Salix Investigational Site

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Tampa : Salix Investigational Site

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Tampa : Meridien Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Wellington : Venra Clinical Studies, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Wellington : Venra Clinical Studies, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

West Palm Beach : Palm Beach Research Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

West Palm Beach : Palm Beach Research Center

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Winter Haven : Clinical Research of Central Florida

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Winter Park : National Pain Research Institute, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Alpharetta : CSI Research Inc

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Investigational Product in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)

Columbus : Southeast Regional Research Group - Columbus

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study To Evaluate The Long-Term Safety And Tolerability Of Cb-5945 For The Treatment Of Opioid-Induced Constipation In Adults Taking Opioid Therapy For Chronic Non-Cancer Pain

Stockbridge : Clinical Research Atlanta

Study of an investigational product for Chronic Constipation

Woodstock : North Georgia Clinical Research

Constipation? Abdominal Bloating?

Atlanta : The Kaufmann Clinic, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Atlanta : Mount Vernon Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Atlanta : Mount Vernon Clinical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Atlanta :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Austell : CPM Research Institute, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Austell : CPM Research Institute, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Austell :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Blue Ridge : River Birch Research Alliance, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Canton : Etowah Regional Medical Services, PC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Canton : Etowah Regional Medical Services, PC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Columbus : Southeast Regional Research Group

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Columbus : Southeast Regional Research Group

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Columbus :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Johns Creek : North Chattahoochee Family Physicians LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Marietta : Drug Studies America

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Marietta : Atlanta Gastroenterology Associates, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Marietta : Drug Studies America

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Marietta :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Perry : Middle Georgia Clinical Research Center, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sandy Springs : Mount Vernon Clinical Research, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Savannah : Savannah Pain Management

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Snellville : Georgia Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Snellville :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Stockbridge : Clinical Research Atlanta

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Stockbridge : Advanced Digestive Care Center , PC

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Woodstock : North Georgia Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Blackfoot : Elite Clinical Trials, Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Boise : CTL Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Boise : Injury Care Medical Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Boise : The Pain Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Eagle : CTL Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Idaho Falls : Rosemark WomenCare Specialists

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Meridian : Advanced Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Meridian : Advanced Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Meridian :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Bloomington : Millennium Pain Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Bolingbrook :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chicago : Chicago Anesthesia Pain Specialists

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Chicago : Apex Medical Research, AMR, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Chicago : Chicago Anesthesia Pain Specialists

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Chicago :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chicago : Medex Healthcare Research, Inc

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Peoria : Accelovance

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Rockford : Rockford Gastroenterology Associates, Ltd.

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Rockford : Rockford Gastroenterology Associates, Ltd.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Rockford : Rockford Gastroenterology Associates

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Elkhart : Indiana Medical Research, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Evansville : MediSphere Medical Research Center, LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Evansville : Global Scientific Innovations, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Evansville : MediSphere Medical Research Center, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Evansville : MediSphere Research Medical Research Center, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Evansville : Global Scientific Innovations, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Evansville :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Michigan City : LaPorte County Institute for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Iowa City : University of Iowa Hospitals and Clinics

Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.

West Des Moines :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Augusta : Heartland Research Associates, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Kansas City : University of Kansas Medical Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Kansas City : University of Kansas Medical Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Leawood :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Wichita : Professional Research Network of Kansas, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Wichita : Heartland Research Associates, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Wichita : Professional Research Network of Kansas, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Edgewood : OtriMed Clinical Research

Low Back Pain with Opiate Induced Constipation

Lexington : Kentucky Medical Research

Constipation

Lexington : University of Kentucky Chandler Medical Center

Do You Have Cancer and Problems With Constipation?

Edgewood : Otrimed Corporation

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Lexington : Kentucky Medical Research Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Madisonville : Commonwealth Biomedical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Madisonville : Commonwealth Biomedical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Owensboro :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Owensboro : Research Integrity, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Bastrop : Delta Research Partners, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Baton Rouge : L.A. Spine and Sports Medicine

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Baton Rouge :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Covington : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Covington : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Lake Charles : Centex Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Lake Charles : Centex Studies, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Marrero : DCT - Southern Pain Relief, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Marrero : DCT - Southern Pain Relief, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Metairie : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Metairie : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Monroe : Louisiana Pain Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Monroe :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

New Orleans : New Orleans Center for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

New Orleans : LSU Health Faculty Practice Clinic

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

New Orleans : Women Under Study, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Shreveport : Louisiana Research Center, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Shreveport : Louisiana Research Center, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Shreveport :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chevy Chase : Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Hollywood : Mid-Atlantic Medical Research Centers

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Laurel : Maryland Digestive Disease Research, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Brockton : Beacon Clinical Research

Are you Suffering from Chronic Idiopathic Constipation?

Brockton : Beacon Clinical Research

Chronic Low Back Pain & Constipation

Roslindale : Boston Clinical Trials Updated

Frustrated with your chronic constipation?

Boston : Boston Clinical Trials

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Boston : Boston Clinical Trials, INC.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Boston : Massachusetts General Hospital

A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders

Brockton : Beacon Clinical Research, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Brockton : Beacon Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Brockton : Miray Medical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Brockton : Beacon Clinical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Fall River : NECCR Internal Medicine & Cardiology Associates, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Fall River : NECCR Internal Medicine & Cardiology Associates, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Watertown :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Watertown : Bay State Clinical Trials, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Worcester : Clinical Pharmacology Study Group

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Ann Arbor : University of Michigan Med Center

Colonic Transit Time Validation Study

Bay City : Great Lakes Research Group, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Chelsea : IHA Chelsea Family & Internal Medicine

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Chesterfield :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chesterfield : Clinical Research Institute of Michigan, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Kalamazoo : Bayer Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Paw Paw : Women's Health Care Specialists, PC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Rochester : Remedica, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Traverse City :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Troy : William Beaumont Hospital

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Minneapolis : Colon and Rectal Surgery Associates

Effect of TU-100 in Patients With Functional Constipation

Rochester : Mayo Clinic

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Rochester : Mayo Clinic

A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation

Biloxi : The Center for Clinical Trials

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Jackson : Gastrointestinal Associates, P.A.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Jackson : CRC of Jackson, LLC at Jackson Medical Clinic

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Jackson : GI Associates and Endoscopy Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Jackson : Gastrointestinal Associates, PA

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Hazelwood : Healthcare Research Network

Do you have Constipation? Are you 18+ years old? If so, you may qualify for our study! Call us today to find out more information.

Hazelwood : Healthcare Research Network

Do you have Constipation? Are you 18+ years old? If so, you may qualify for our study! Call us today to find out more information.

Florissant : HealthCare Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Hazelwood : HealthCare Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Hazelwood :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Lee's Summit : Midwest Gastroenterology Partners

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Mexico : Center for Digestive and Liver Diseases, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

St. Louis : CenterPointe Institute of Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

St. Louis : Prevention First Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

St. Louis : Sundance Clinical Research, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

St. Louis :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

St. Louis : St. Louis Center for Clinical Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Missoula : Montana Medical Research, Inc.

Constipation from Prescription Pain Medication? You may want to know about this

Missoula : Montana Medical Research, Inc.

Do your pain medications cause you to suffer from constipation?

Billings : Montana Health Research Institute, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Missoula :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Grand Island : Internal Medical Associates of Grand Island, PC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Omaha : Quality Clinical Research, Inc.

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Omaha : Quality Clinical Research, Inc

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Omaha :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Omaha : Quality Clinical Research, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Las Vegas : AB Clinical Trials

Celiac Disease

Las Vegas : AB Clinical Trials

Constipation Secondary to Opioid Pain Medication

Las Vegas : AB Clinical Trials

Pain Management and Constipation Secondary to Opioid Pain Medication Study

Henderson : Lovelace Scientific Resources

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Las Vegas : Advanced Biomedical Research of America

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Las Vegas : AB Clinical Trials

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Las Vegas : Om Medical

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Las Vegas : Clinical Research Consortium

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Las Vegas : Clinical Research Consortium

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Las Vegas : Ladner Family Practice

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Las Vegas :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Newington : ActivMed Practices & Research, Inc. NH Updated

Do You Suffer From Constant Constipation?

Atco : Atco Medical Associates, P.C.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Belvidere : Wellness and Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Berlin :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Elizabeth : Central Jersey Medical Research Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Stratford : University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Toms River : Bio Behavioral Health

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Voorhees : Cooper University Hospital Surgical Center-Voorhees

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Albuquerque : New Mexico Clinical Research & Osteoporosis Center, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Albuquerque :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Brooklyn : Mount Vernon Clinical Research

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Brooklyn : HOSC, Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Brooklyn : LifeLine Research, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Cedarhurst : Five Towns Neuroscience Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Cedarhurst : Five Towns Neuroscience Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Great Neck : Long Island Gastrointestinal Research Group

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Great Neck : Long Island Gastrointestinal Research Group LLP

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Great Neck : Long Island Gastrointestinal Research Group, LLP

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Great Neck :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Kew Gardens : IMA Medical Research, PC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

New Windsor : Mid Hudson Medical Research, PLLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

New York : Brain Resource Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

New York : Research Across America

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

North Massapequa : DiGiovanna Institute for Medical Education & Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

North Massapequa : DiGiovanna Family Care Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Rochester : Translational Pain Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Rochester : University of Rochester

Lubiprostone in Patients With Multiple Sclerosis Associated Constipation

Rochester : Mayo Clinic Rochester

Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

Williamsville : Upstate Clinical Research Associates

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Williamsville : Upstate Clinical Research Associates

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Cary : Clinical Trials of North Carolina

A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C).

Raleigh : Wake Research Associates

Chronic Constipation Study

Salisbury : PMG Research of Salisbury

Tired of being constipated?

Wilmington : PMG Research of Wilmington

Are you constipated?

Winston-Salem : PMG Research of Winston-Salem

Are you constipated?

Winston-Salem : PMG Research of Winston-Salem

What does your IBS-C feel like?

Boone : MediSpect, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Cary : Clinical Trials of North Carolina, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Chapel Hill : UNC Center for Functional GI and Motility Disorders

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Charlotte : Carolina Digestive Health Associates

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Davidson : Carolina Digestive Health Associates, PA

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Elkin : Clinical Trials of America, Inc. / Revival Pain Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Elkin : Clinical Trials of America, Inc. / Revival Pain Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Fayetteville : Cumberland Research Associates, LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Flat Rock : Salix Investigational Site

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Flat Rock : Salix Investigational Site

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Greensboro : PharmQuest, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Greensboro :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Greensboro : LeBauer Research Associates, P.A.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Greensboro : Medoff Medical / Vital re:Search

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

High Point : Peters Medical Research, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

High Point : Peters Medical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

High Point : Peters Medical Research dba Bethany Medical Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

High Point : Peters Medical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

High Point :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Raleigh : Wake Research Associates, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Raleigh : Wake Research Associates

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Raleigh : Wake Research Associates, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Salisbury : PMG Research of Salisbury

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Wilmington : PMG Research of Wilmington

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Winston-Salem : The Center for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Winston-Salem : Clinical Trials of America, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Winston-Salem : Piedmont Medical Research Associates

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Winston-Salem : The Center for Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Winston-Salem : PMG Research of Winston-Salem, LLC

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Winston-Salem :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Winston-Salem : PMG Research of Winston-Salem, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Cleveland : Rapid Medical Research, Inc. (RMR)

Have you been suffering from chronic constipation for over 6 months?

Cleveland : Rapid Medical Research, Inc. (RMR)

Is you pain medication causing you constipation?

Columbus : Radiant Research - Columbus

Clinical Research Study for Constipation

Beavercreek : Clinical Inquest Center Ltd.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Centerville : Valley Medical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Cincinnati : Gastroenterology Research Consultants of Greater Cincinnati

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Cincinnati : Hightop Medical Research Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Cincinnati : Gastroenterology Research Consultants of Greater Cincinnati

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Cincinnati : Community Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Cleveland : Rapid Medical Research, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Cleveland : Rapid Medical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Cleveland : Rapid Medical Research , Inc

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Cleveland :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Cleveland : Salix Investigational Site

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Cleveland : Salix Investigational Site

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Columbus : Columbus Clinical Research Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Columbus : The Ohio State University Wexner Medical Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Columbus : Hometown Urgent Care

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Columbus : Hometown Urgent Care and Occupational Health

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Columbus : Radiant Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Columbus :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Columbus : Hometown Urgent Care and Occupational Health

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Dayton : Hometown Urgent Care and Occupational Health

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Dayton : Dayton Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Dayton : Gastrointestinal and Liver Diseases Consultants

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Dayton :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Franklin : Prestige Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Groveport : Hometown Urgent Care

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Mentor :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Mentor : Great Lakes Gastroenterology

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Moraine : Providence Health Partners - Center for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Springfield : Hometown Urgent Care and Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Toledo : Toledo Clinic Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Wadsworth : Family Practice Center of Wadsworth

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Norman : Central Sooner Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Oklahoma City : Clinical Research Associates, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Oklahoma City : Oklahoma Foundation for Digestive Research

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Oklahoma City : Hillcrest Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Oklahoma City : Health Research Institute

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Oklahoma City : IPS Research Company

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Oklahoma City : Hillcrest Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Oklahoma City :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Oklahoma City : Oklahoma Foundation for Digestive Research

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Oklahoma City : Oklahoma Foundation for Digestive Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Oklahoma City : Lynn Health Science Institute

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Medford : Sunstone Medical Research, LLC

Are you experiencing constipation due to take prescription pain medications (opioids)?

Eugene : Williamette Valley Clinical Studies

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Eugene :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Medford : Sunstone Medical Research, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Medford :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Altoona : Blair Orthopedic Associates, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Altoona :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Jenkintown : The Clinical Trial Center, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Jenkintown : The Clinical Trial Center, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Jenkintown :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Johnstown : Central Pennsylvania Pain Management

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Johnstown : Central Pennsylvania Pain Management

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Levittown : Family Medical Associates

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Levittown : Family Medical Associates, Research Department

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Mechanicsburg : Central Pennsylvania Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Philadelphia : Founders Research Corporation

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Philadelphia :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Phoenixville : PMA Medical Specialists, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Phoenixville : PMA Medical Specialist, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Pittsburgh : Clinical Trials Research Services, LLC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Pittsburgh : UPMC St. Margaret

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Pittsburgh : Clinical Trials Research Services, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Pittsburgh : Clinical Trials Research Services, LLC

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Red Lion : Dairyland Medical Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Souderton : Mainline Gastroenterology Associates

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

State College : University Orthopedics Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tipton : Tipton Medical & Diagnostic Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tipton : Tipton Medical & Diagnostic Center

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

University Park : Penn State University

Influence of a Delivery System on the Efficacy of a Probiotic Intervention

Cranston : New England Center for Clinical Research, Inc

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Cumberland :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Warwick : Omega Medical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Warwick : Omega Medical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Greer : Radiant Research - Greer

Clinical Research Study for Constipation

Anderson : Anderson Gastroenterology Associates

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Anderson :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Charleston : Pain Research of Charleston

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Columbia : Consultants in Gastroenterology

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Greer : Internal Medicine of Greer Research LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Greer : Radiant Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Myrtle Beach : Family Medicine of SayeBrook, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Myrtle Beach : Family Medicine of SayeBrook, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

North Charleston :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

North Charleston : Southeast Medical Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Spartanburg : Spartanburg Medical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Spartanburg : Spartanburg Medical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Summerville : Palmetto Clinical Research

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Rapid City : Health Concepts Wellness Center

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Rapid City :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chattanooga : ClinSearch

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Chattanooga : Southeastern Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Chattanooga :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Chattanooga : ClinSearch, LLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Franklin : HCCA Clinical Research Solutions

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Franklin : Franklin Gastroenterology, PLLC

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Germantown : Memphis Gastroenterology Group, PC

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Hermitage : Associates in Gastroenterology, LLC

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Hermitage : Associates in Gastroenterology

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Jackson : HCCA Clinical Research Solutions

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Jackson : Jackson Clinic, PA

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Jackson : Regional Research Institute

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Kingsport : Gastroenterology Associates Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Memphis :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Milan :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

New Tazewell : Heartland Medical PC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Dallas : Galenos Research

CONSTIPATION FROM PRESCRIPTION PAIN MEDICATION? You may want to know about this.

Dallas : ACRC TRIALS

Do you have Constipation?

Dallas : Radiant Research - Dallas, North

Research Study for Constipation

Allen : Research Facility

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Arlington : Global Institute for Spine and Joint Care

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Athens : Medical Arts Clinic

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Athens : Medical Arts Clinic

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Austin : Austin Center for Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Austin : FutureSearch Trials of Neurology

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Austin : Austin Center for Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Austin : FutureSearch Trials of Neurology

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Austin :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Austin : Salix Investigational Site

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Austin : Salix Investigational Site

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Austin : DCT-AACT, LLC dba Discovery Clinical Trials

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Dallas : KRK Medical Research

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Dallas : Galenos Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Dallas : FutureSearch Trials of Dallas, L.P.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Dallas : Renaissance Clinical Research and Hypertension of Texas, PLLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Dallas : Galenos Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Dallas : FutureSearch Trials of Dallas, L.P.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Dallas : KRK Medical Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Dallas :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Houston : Pioneer Research Solutions, Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Houston : Clinical Trial Network

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Houston : Centex Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Houston : Pioneer Research Solutions, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Houston : Medex Healthcare Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Houston : Advanced Clinical Research Center of Houston, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Houston : Pinnacle Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Houston : Baylor College of Medicine, Baylor Clinic

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Houston : JVC Family Medicine

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Pioneer Research Solutions, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Diversified Medical Practices, PA

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : One Stop Medical Care

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Medex Healthcare Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Jacon Medical Research Associates, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Westbury Medical Clinic

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Clinical Trial Network

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Pinnacle Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Houston : Gastroenterology Consultants P.A

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Houston : Clinical Trial Network

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Houston :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Houston : Centex Studies, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Humble : Spring Gastroenterology Associates

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Hurst :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Katy : Research Across America

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Longview : DCOL Center for Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

North Richland Hills : North Hills Medical Research, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

North Richland Hills : North Hills Medical Research, Inc.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Pasadena : Digestive Health Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Plano : Clinical Investigations of Texas

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Plano : Clinical Investigations of Texas

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

San Antonio : Texas Physical Medicine & Rehabilitation Institute

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

San Antonio : River City Anesthesia

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

San Antonio : Texas Medical Research Associates, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

San Antonio : Quality Research, Inc

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

San Antonio : Texas Medical Research Associates , LLC

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

San Antonio : Sun Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

San Antonio : Paragon Research Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

San Antonio :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

San Antonio : Physician PrimeCare Research Institute, PLLC dba Health Texas Research Institute

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

San Antonio : Quality Research, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Spring : Spring Gastroenterology

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Sugar Land : Pioneer Research Solutions, Inc.

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Sugar Land : Discovery Clinical Trials

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Sugar Land : Pioneer Research Solutions , Inc

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Sugar Land : Breco Research

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Sugar Land : Pioneer Research Solutions, Inc.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Tomball : Martin Diagnostic Clinic

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Tomball : Martin Diagnostic Clinic

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Salt Lake City : Lifetree Clinical Research Updated

A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Long-Term Safety and tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults taking Opiod Therapy for Chronic Non-Cancer Pain

Clinton : Ericksen Research and Development

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Clinton : Ericksen Research and Development

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Ogden : Advanced Research Institute

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Orem : Aspen Clinical Research, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Salt Lake City : Alpine Medical Group

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Salt Lake City : Utah Clinical Trials, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Salt Lake City : Highland Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Salt Lake City : Utah Clinical Trials, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Salt Lake City : Alpine Medical Group

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Salt Lake City :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

West Jordan : Advanced Clinical Research

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

West Jordan : Advanced Clinical Research

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

West Jordan :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Charlottesville : Charlottesville Medical Research

Chronic Constipation Study

Charlottesville : Charlottesville Medical Research Center

Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

Chesapeake : Gastroenterology Associates of Tidewater

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Christiansburg :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Christiansburg : New River Valley Research Institute

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Danville : Danville Orthopedic Clinic, Inc.

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Lynchburg : Blue Ridge Medical Research/Gastroenterology Associates of Central Virginia

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Richmond : Clinical Research Partners, LLC

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Richmond : Dominion Medical Associates, Inc

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Richmond : Clinical Research Partners, LLC

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Richmond : Dominion Medical Associates, Inc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Virginia Beach : APM Spine & Sports Physicians

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Virginia Beach : APM Spine & Sports Physicians

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Lynnwood : Clinical Trials of America, Inc

Do you suffer from opioid-induced constipation due to low back pain medication?

Bellevue : Northwest Gastroenterology Associates

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Bellevue :

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Bothell : Pacific Institute of Medical Science

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Seattle : Virginia Mason Meidical Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Spokane : Rowan Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Spokane : Spokane Internal Medicine

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Madison : Covance Madison Updated

Do you suffer from Occasional Constipation?

Milwaukee : Wisconsin Center for Advanced Research Division of GI Associates, LLC

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Waukesha : Aurora Health Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Antwerpen 7 : Gastro-Kliniek cvba

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bruxelles : Cliniques Universitaires St Luc

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Deurne : GP / Huisartsenpraktijk De Regenboog

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Leuven : UZ Leuven Gasthuisberg

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Leuven : UNIVERSITY OF LEUVEN, UNVERSITY HOSPITAL, Gasthuisberg

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Liege : CHU Sart Tilman

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Wetteren : Private Practice

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Ceará : Departamento de Fisiologia e Farmacologia

Study of Efficacy of Association of Senna Alexandrina Mill and Associations on Functional Intestinal Constipation

Sofia : 4 MHAT

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bathurst : Maritime Medical Research Center

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

DrummondvilleQC : Rhodin Recherche Clinique

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Hamilton : McMaster University Dept of Gastrointerology St. Joseph's Healthcare

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

London : St. Joseph's Hospital

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Ottawa : Meadowlands Family Health Center

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Penticton : Medical Arts Health Research Group Penticton

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Sarnia : London Road Diagnostic Clinic

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Sarnia : Sarnia Institute of Clinical Research

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Toronto : Dr Anil K Gupta Medicine Professional Corp.

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients With Chronic Idiopathic Constipation

Toronto : Prime Health Clinical Research Organization

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Toronto : Canadian Phase Onward Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Toronto : Toronto Digestive Disease Associates, Inc.

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Winnipeg : John Buhler Research Center

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Beijing : Site reference ID/Investigator# 94519

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Guangzhou : Updated New

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

Guangzhou : Site reference ID/Investigator# 94521

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Guangzhou City : Site reference ID/Investigator# 95475

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Hong Kong : Princess Margaret Hospital

Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method

Hong Kong : Caritas Medical Centre

Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method

Hong Kong : Yan Chai Hospital

Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method

Shanghai : Site reference ID/Investigator # 94516

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Shanghai : Site reference ID/Investigator # 94518

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Shanghai : Site reference ID/Investigator # 94517

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Wuhan : Updated New

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

Wuhan : Site reference ID/Investigator # 94515

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Zagreb : University Hospital Centre "Sisters of Mercy"

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children

Brno : Fakultni nemocnice u sv. Anny y Brne

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Brno : CCBR Czech Republic Brno

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Hradec Kralove : HK - s.r.o.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Karlovy Vary : KKN a.s.

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Most : Krajska zdravotni, a.s. - Nemocnice, Most, o.z.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Olomouc : Fakultni nemocnice Olomouc

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Pardubice : CCBR Czech Republic Pardubice

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Prague : MONSE s.r.o.

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Prague 10 : Universtiy Hospital Kralovske Vinhorady

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Praha 10 : Clintrial s.r.o.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Praha 4 - Krc : Thomayerova nemocnice

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Rychnov nad Kneznou : CTC Rychnov nad Kneznou, s.r.o.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Slany : Hospital Slany

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Sternberk : CTCenter MaVe s.r.o

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Usti nad Orlici : Orlickoustecka nemocnice

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Vysoke Myto : Vysokomytska nemocnice, p.o

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Zlin : Krajska Nemocnice T. Bati a.s., Interni oddeleni - klinika IPVZ; Nemocnicni Lekarna

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Zlin : Krajska Nemocnice T. Bati a.s.

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Znojmo : Nemocnice Znojmo p.o.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Aalborg : CCBR DK Aalborg

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Ballerup : CCBR DK Ballerup

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Vejle : CCBR DK Vejle

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Cairo : Site reference ID/Investigator# 95900

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

El Sharkya : Site reference ID/Investigator# 95901

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Giza : Site reference ID/Investigator# 95903

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Giza : Site reference ID/Investigator# 95902

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Helsinki : Mehiläinen Töölö

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms

Amiens : CHU - Hopital Nord, service gastro-enterologie et hepatologie

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Angers : ARK Clinical Research (Proust)

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Angers : ARK Clinical Research - Chanzy

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Angers : ARK Clinical Research (Jean XXIII)

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Avrille : ARK Clinical Research

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bobigny : CRNH-CRV Avicenne Hospital

Effects of scFOS on Stool Frequency in People With Functionnal Constipation

Bobigny : Hopital Avicenne, Centre d'exploitation fonctionnelle et reducation digestive

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Dijon Cedex : Service de Gastroenterologie & INSERM CIC-P 803 - CHU de Dijon

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Lyon cedex 3 : Hôpital Edouard Herriot

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Nice : Hopital Archet 2- service gastro-enterologie et hepatologie

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Paris : Diaconesses Hospital

Study of the Efficacy of Eductyl® Versus Placebo for Treatment of Patients With Dyschesia Treated by Rectal Rehabilitation

Plessis : ARK Clinical Research

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Rennes : Hôpital Pontchaillou - Service des Maladies de l'Appareil Digestif

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Suresnes : Hôpital Foch, Service de Chirurgie Générale et Digestive

Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia

Thouars : Cabinet Médical

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Vendome : ARK Clinical Research

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bad Saarow : DE005

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Berlin : emovis GmbH

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Berlin : Analyze & Realize Ag

IQP-PO-101 for the Regulation of Bowel Movement Frequency

Berlin : DE009

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Berlin : DE030

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Berlin : DE007

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Berlin : DE021

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Bochum : DE020

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Böhlen : DE023

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Cottbus : DE028

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Dresden : DE012

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Essen : DE032

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Frankfurt : DE017

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Frankfurt : DE003

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Görlitz : DE011

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Hamburg : DE031

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Hannover : DE013

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Kiel : DE014

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Kiel : DE027

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Kiel : Site DE001

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Köln : DE029

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Köln : DE008

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Leipzig : Gastroenterologie und Hepatologie am Johannisplatz

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Leipzig : DE004

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Leipzig : DE018

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Magdeburg : DE015

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Mainz : DE006

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Mittweida : DE002

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Rudolstadt : DE010

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Schwerin : DE025

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Stadtroda : DE019

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Weinheim : DE016

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Westerstede : DE024

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Wiesbaden : Fachartzpraxis für Innere Medizin

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Wiesbaden : DE026

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Wiesbaden : DE022

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Tel Aviv : Tel Aviv Souraski medical Center

Safety Evaluation of the Vibrating Capsule

Milan : Istituto Clinico Humanitas

Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time

Hokkaido :

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Kansai :

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Kantou :

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Kyusyu :

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Kuala Lumpur N/A : Updated New

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

Guadalajara : Site reference ID/Investigaot# 94525

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Mexico City : Site refernce ID/Investigator# 94527

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Tampico : Site reference ID/Investigator# 94523

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Amsterdam : VU Medisch Centrum

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Beek : PT&R / PreCare Trial & Recruitment

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Ede : Ziekenhuis Gelderse Vallei

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Maastricht : Maastricht Universitair medisch Centrum

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Oslo : Dept of Anesthesiology, Oslo University Hospital, Ullevaal

A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy

Quezon : Camp Crame

The Effect of Milk Powder With Fiber and Probiotics on Digestive Habits and General Health Well-being of Selected Filipino Mothers.

Taguig : Camp Bagong Diwa

The Effect of Milk Powder With Fiber and Probiotics on Digestive Habits and General Health Well-being of Selected Filipino Mothers.

Bielsko-Biala : Nzoz Darmed Majdak i Wspolnicy Spolka Jawna

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Bydgoszcz : Niepubliczny Zaklad Opieki Zdrowotnej, Dom Sue Ryder

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Bydgoszcz : Niepubliczny Zaklad Opieki Zdrowotnej VITAMED

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Bydgoszcz : Gabinet Lekarski Janusz Rudziński

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Gdansk : Centrum Badan Klinicznych P.I. House Sp. z. o. o.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Gdansk : Niepubliczny Zaklad Opieki Zdrowotnej "Przychodnia Morena" Poradnia Leczenia Bolu

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Katowice : Centrum Medyczne DENDRYT

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Lublin : Zespot Poradni Specjalistycznych REUMED

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Lublin : Research Facility

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Lublin : Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Lublin : Instytut Medycyny Wsi im. Witolda Chodźki - Zaklad Endoskopowych Badań Kliniczncyh

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Sopot : Endoskopia Sp. z o.o.

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Torun : Lecznice Citomed Sp. z. o. o.

Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain

Torun : Indywidualna Specjalistyczna Praktyka Lekarska w Dziedzinie Chirurgii Ogólnej i Gastroenterologii

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Warszawa : NZOZ Vivamed

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bucuresti : SC Mediclass Sananova SRL

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bucuresti : Endocenter Medicina Integrativa SRL

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bucuresti : Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bucuresti : SC Quantum Medical Center SRL

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Bucuresti, : Centrul Medical Humanitas

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Oradea : CMI Dr. Lenghel Augustin

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Ploiesti : Centrul Medical Valahia SRL

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Sibiu : Spitalul Clinic Judetean de Urgenta Sibiu

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Timisoara : Centrul Medical Tuculanu SRL

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Solna : Karolinska University Hospital

Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome

Bath : Oldfield Surgery

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Belfast : Ballygomartin Group Practice

A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy

Cheltenham : Salix Investigational Site

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Cheltenham : Salix Investigational Site

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation

Chesterfield : Avondale Surgery

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Coventry : University Hospital & Warwickshire -

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Durham : County Durham & Darlington NHS Foundation Trust

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Hinckley : Burbage Surgery

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Irvine : Townhead Research

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Leamington Spa : Sherbourne Medical Centre

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Manchester : Wythenshawe Hospital

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

Whitechapel, London : Barts Health NHS Trust

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Constipation Clinical Trials

Alabama

Arizona

Arkansas

California

Colorado

Connecticut

Florida

Georgia

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Virginia

Washington

Wisconsin

Belgium

Brazil

Bulgaria

Canada

China

Croatia

Czech Republic

Denmark

Egypt

Finland

France

Germany

Israel

Italy

Japan

Malaysia

Mexico

Netherlands

Norway

Philippines

Poland

Romania

Sweden

United Kingdom